Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Geron Corporation
Geron Corporation_20100121
  

Geron Corporation patents

Recent patent applications related to Geron Corporation. Geron Corporation is listed as an Agent/Assignee. Note: Geron Corporation may have other listings under different names/spellings. We're not affiliated with Geron Corporation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Geron Corporation-related inventors




Date Geron Corporation patents (updated weekly) - BOOKMARK this page
05/11/17Modified oligonucleotides for telomerase inhibition
02/23/17Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
12/15/16Synthesis of protected 3'-amino nucleoside monomers
10/27/16Methods of polynucleotide preparation using multivalent cation salt compositions
09/15/16Method for eliciting an immune response to human telomerase reverse transcriptase
06/30/16C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
06/23/16Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
05/12/16Rna amidates and thioamidates for rnai
12/31/15Oligonucleotide conjugates
12/31/15Modified oligonucleotides for telomerase inhibition
12/17/15Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors
12/03/15Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
12/03/15Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
11/26/15Oligonucleotide compositions and methods of making the same
11/12/15Modified oligonucleotides for telomerase inhibition
11/12/15Modified oligonucleotides for telomerase inhibition
10/22/15Guanine analogs as telomerase substrates and telomere length affectors
09/10/15Method for eliciting an immune response to human telomerase reverse transcriptase
06/04/15Method for identification of sensitivity of a patient to telomerase inhibition therapy
04/23/15Phosphorodiamidate backbone linkage for oligonucleotides
03/26/15Nucleic acids encoding inactive variants of human telomerase
03/12/152'-arabino-fluorooligonucleotide n3'-->p5' phosphoramidates: their synthesis and use
02/05/15Synthesis of protected 3'-amino nucleoside monomers
10/09/14Primate pluripotent stem cell expansion without feeder cells and in the presence of fgf and matrigel or engelbreth-holm-swarm tumor cell preaparation
09/04/14Telomere length measurement in formalin-fixed, paraffin embedded (ffpe) samples by quantitative pcr
05/15/14Synthetic surfaces for culturing stem cell derived cardiomyocytes
05/15/14Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
12/19/13Differentiation and enrichment of islet-like cells from human pluripotent stem cells
09/26/13Oligonucleotide conjugates
03/14/13Modified oligonucleotides for telomerase inhibition
12/27/12Modified oligonucleotides for telomerase inhibition
06/14/12Screening methods for human embryonic stem cells
05/24/12Modified oligonucleotides for telomerase inhibition
05/03/12Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
12/29/11Human telomerase catalytic subunit
10/27/11Method for identification of sensitivity of a patient to telomerase inhibition therapy
09/01/11Assay for telomerase activity
03/24/11Compositions and methods for increasing telomerase activity
12/30/10Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes
12/16/10Culture system for rapid expansion of human embryonic stem cells
09/30/10Synthetic surfaces for differentiating stem cells into cardiomyocytes
09/23/10Differentiation and enrichment of islet-like cells from human pluripotent stem cells
04/29/10Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors
01/21/10Combined telomerase inhibitor and gemcitabine for the treatment of cancer
01/21/10Oligonucleotide conjugates
12/10/09Use of tgf beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells
11/26/09Neural cell populations from primate pluripotent stem cells
11/19/09Modified oligonucleotides for telomerase inhibition
10/22/09Genes that are up- or down-regulated during differentiation of human embryonic stem cells
10/01/09Differentiation of primate pluripotent stem cells to hematopoietic lineage cells
06/04/09Hair follicle pharmacodynamic assay for telomerase activity
04/30/09Protein and peptide fragments from mouse telomerase reverse transcriptase
01/21/10Oligonucleotide conjugates







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Geron Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Geron Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';